Supernus Pharmaceuticals (SUPN) EPS (Basic): 2011-2025
Historic EPS (Basic) for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Sep 2025 value amounting to -$0.80.
- Supernus Pharmaceuticals' EPS (Basic) fell 214.29% to -$0.80 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.33, marking a year-over-year decrease of 130.49%. This contributed to the annual value of $1.34 for FY2024, which is 6600.00% up from last year.
- Latest data reveals that Supernus Pharmaceuticals reported EPS (Basic) of -$0.80 as of Q3 2025, which was down 300.00% from $0.40 recorded in Q2 2025.
- In the past 5 years, Supernus Pharmaceuticals' EPS (Basic) registered a high of $0.70 during Q3 2024, and its lowest value of -$0.80 during Q3 2025.
- Over the past 3 years, Supernus Pharmaceuticals' median EPS (Basic) value was $0.02 (recorded in 2023), while the average stood at $0.07.
- As far as peak fluctuations go, Supernus Pharmaceuticals' EPS (Basic) soared by 1,900.00% in 2024, and later slumped by 9,369.63% in 2025.
- Quarterly analysis of 5 years shows Supernus Pharmaceuticals' EPS (Basic) stood at $0.05 in 2021, then surged by 840.00% to $0.47 in 2022, then crashed by 95.74% to $0.02 in 2023, then surged by 1,300.00% to $0.28 in 2024, then slumped by 214.29% to -$0.80 in 2025.
- Its EPS (Basic) stands at -$0.80 for Q3 2025, versus $0.40 for Q2 2025 and -$0.21 for Q1 2025.